Notice: Expanding the list of generic drug submissions under review

You can read the full story here: Notice: Expanding the list of generic drug submissions under review.
2024-02-23 16:30:00 February 23, 2024 Our file number: 23-109491-316 The Generic Drug Submissions Under Review (GDSU) List helps make Health Canada’s review processes more transparent. The list provides Canadians with information about generic versions of brand-name prescription drugs currently under review in Canada. The ADP list includes Abbreviated New Drug Submissions (ANPs) accepted for review … Read more